These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 25327891)
21. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations. Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931 [TBL] [Abstract][Full Text] [Related]
22. Neuropathological changes in a mouse model of progressive myoclonus epilepsy: cystatin B deficiency and Unverricht-Lundborg disease. Shannon P; Pennacchio LA; Houseweart MK; Minassian BA; Myers RM J Neuropathol Exp Neurol; 2002 Dec; 61(12):1085-91. PubMed ID: 12484571 [TBL] [Abstract][Full Text] [Related]
23. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression. Franceschetti S; Sancini G; Buzzi A; Zucchini S; Paradiso B; Magnaghi G; Frassoni C; Chikhladze M; Avanzini G; Simonato M Neurobiol Dis; 2007 Mar; 25(3):675-85. PubMed ID: 17188503 [TBL] [Abstract][Full Text] [Related]
24. Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Rinne R; Saukko P; Järvinen M; Lehesjoki AE Ann Med; 2002; 34(5):380-5. PubMed ID: 12452481 [TBL] [Abstract][Full Text] [Related]
25. The epilepsy, the protease inhibitor and the dodecamer: progressive myoclonus epilepsy, cystatin b and a 12-mer repeat expansion. Lalioti MD; Antonarakis SE; Scott HS Cytogenet Genome Res; 2003; 100(1-4):213-23. PubMed ID: 14526183 [TBL] [Abstract][Full Text] [Related]
26. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene]. de Haan GJ; Halley DJ; Deelen WH; Lindhout D Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222 [TBL] [Abstract][Full Text] [Related]
27. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation. Kim SU; Park YH; Min JS; Sun HN; Han YH; Hua JM; Lee TH; Lee SR; Chang KT; Kang SW; Kim JM; Yu DY; Lee SH; Lee DS J Neuroimmunol; 2013 Jun; 259(1-2):26-36. PubMed ID: 23602274 [TBL] [Abstract][Full Text] [Related]
28. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. Ghosh M; Xu Y; Pearse DD J Neuroinflammation; 2016 Jan; 13():9. PubMed ID: 26757726 [TBL] [Abstract][Full Text] [Related]
29. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs. Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI Cells; 2022 Nov; 11(21):. PubMed ID: 36359887 [TBL] [Abstract][Full Text] [Related]
31. In depth behavioral phenotyping unravels complex motor disturbances in Pollari E; Tegelberg S; Björklund H; Kälviäinen R; Lehesjoki AE; Haapalinna A Front Behav Neurosci; 2023; 17():1325051. PubMed ID: 38179183 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia. Cui YQ; Zhang LJ; Zhang T; Luo DZ; Jia YJ; Guo ZX; Zhang QB; Wang X; Wang XM Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):422-8. PubMed ID: 19843098 [TBL] [Abstract][Full Text] [Related]
33. Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models. Benson MJ; Manzanero S; Borges K Epilepsia; 2015 Jun; 56(6):895-905. PubMed ID: 25847097 [TBL] [Abstract][Full Text] [Related]
35. No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy. Mumoli L; Tarantino P; Michelucci R; Bianchi A; Labate A; Franceschetti S; Marini C; Striano P; Gagliardi M; Ferlazzo E; Sofia V; Pennese L; Annesi G; Aguglia U; Guerrini R; Zara F; Gambardella A; Epilepsia; 2015 Apr; 56(4):e40-3. PubMed ID: 25752200 [TBL] [Abstract][Full Text] [Related]
36. Thickened skull, scoliosis and other skeletal findings in Unverricht-Lundborg disease link cystatin B function to bone metabolism. Suoranta S; Manninen H; Koskenkorva P; Könönen M; Laitinen R; Lehesjoki AE; Kälviäinen R; Vanninen R Bone; 2012 Dec; 51(6):1016-24. PubMed ID: 23010349 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Alakurtti K; Virtaneva K; Joensuu T; Palvimo JJ; Lehesjoki AE Gene; 2000 Jan; 242(1-2):65-73. PubMed ID: 10721698 [TBL] [Abstract][Full Text] [Related]
38. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. Kim YJ; Hwang SY; Oh ES; Oh S; Han IO J Neurosci Res; 2006 Oct; 84(5):1037-46. PubMed ID: 16881054 [TBL] [Abstract][Full Text] [Related]
39. Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons. D'Amato E; Kokaia Z; Nanobashvili A; Reeben M; Lehesjoki AE; Saarma M; Lindvall O Eur J Neurosci; 2000 May; 12(5):1687-95. PubMed ID: 10792446 [TBL] [Abstract][Full Text] [Related]